Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.

Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.

Item
http://www.wikidata.org/entity/Q36310191
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.Hormone receptor status of contralateral breast cancers: analysis of data from the US SEER population-based registries.The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient miceAssociation of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancerInteractions of the anticancer drug tamoxifen with lipid membranes.Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cellsIf progesterone is blamed for breast cancer development, why are we still using tamoxifen?Tissue banking, bioinformatics, and electronic medical records: the front-end requirements for personalized medicine.Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.Steroid hormone receptors as prognostic markers in breast cancer.Phosphorylation of NTRK1 at Y674/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer.Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer.Potential anti-genotoxic effect of sodium butyrate to modulate induction of DNA damage by tamoxifen citrate in rat bone marrow cells.Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.Primary ductal adenocarcinoma of lacrimal gland: Two case reports and review of the literature.
P2860

Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients.

Item
http://www.wikidata.org/entity/Q36310191
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Survival benefit of tamoxifen ...... grade breast cancer patients.
@ast
Survival benefit of tamoxifen ...... grade breast cancer patients.
@en
type
label
Survival benefit of tamoxifen ...... grade breast cancer patients.
@ast
Survival benefit of tamoxifen ...... grade breast cancer patients.
@en
prefLabel
Survival benefit of tamoxifen ...... grade breast cancer patients.
@ast
Survival benefit of tamoxifen ...... grade breast cancer patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Survival benefit of tamoxifen ...... grade breast cancer patients.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932